178 related articles for article (PubMed ID: 1656508)
21. [Drug therapy of migraine--a review of the literature].
Marterer A; Wessely P
Fortschr Neurol Psychiatr; 1995 Jan; 63(1):1-16. PubMed ID: 7883267
[TBL] [Abstract][Full Text] [Related]
22. [Sumatriptan in clinical practice].
Ferrari MD; Haan J; Visser WH; Saxena PR; Bax WA; Mulder LJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):850-5. PubMed ID: 8387649
[No Abstract] [Full Text] [Related]
23. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
[No Abstract] [Full Text] [Related]
24. Sumatriptan. From molecule to man. An official session at the 8th Migraine Trust International Symposium. London, UK, 28 September 1990. Proceedings.
Eur Neurol; 1991; 31(5):277-344. PubMed ID: 1653133
[No Abstract] [Full Text] [Related]
25. SUMATRIPTAN: a receptor-targeted treatment for migraine.
Moskowitz MA; Cutrer FM
Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
[TBL] [Abstract][Full Text] [Related]
26. [Update migraine therapy].
Jürgens TP
MMW Fortschr Med; 2011 Apr; 153(14):49-52. PubMed ID: 21966870
[No Abstract] [Full Text] [Related]
27. Therapeutic advances in migraine.
Solomon GD
J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
[TBL] [Abstract][Full Text] [Related]
28. [Migraine: new aspects on physiopathology and research].
Edvinsson L
Lakartidningen; 1992 May; 89(22):1993-5. PubMed ID: 1321319
[No Abstract] [Full Text] [Related]
29. Sumatriptan.
Welch K
Cephalalgia; 1992 Aug; 12(4):185. PubMed ID: 1326400
[No Abstract] [Full Text] [Related]
30. Serotonin receptors and headache.
Raskin NH
N Engl J Med; 1991 Aug; 325(5):353-4. PubMed ID: 1647497
[No Abstract] [Full Text] [Related]
31. Sumatriptan, serotonin, migraine, and money.
Lancet; 1992 Jan; 339(8786):151-2. PubMed ID: 1346014
[No Abstract] [Full Text] [Related]
32. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
Peroutka SJ
Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621
[No Abstract] [Full Text] [Related]
33. Pharmacologic treatment of migraine. Comparison of guidelines.
Schuurmans A; van Weel C
Can Fam Physician; 2005 Jun; 51(6):838-43. PubMed ID: 15986940
[TBL] [Abstract][Full Text] [Related]
34. [Sumatriptan (Imigran) to patients with hemiplegic migraine?].
Thomsen LL; Iversen HK; Olesen J
Ugeskr Laeger; 1992 Aug; 154(33):2271. PubMed ID: 1329297
[No Abstract] [Full Text] [Related]
35. New relief for migraine sufferers.
Chaplin S
Nurs J India; 1990 Jan; 81(1):29-30. PubMed ID: 2158086
[No Abstract] [Full Text] [Related]
36. [Antimigrainous agents. General considerations and treatment of the crisis].
Massiou H; Bousser MG
Rev Prat; 1986 Jan; 36(5):193-8. PubMed ID: 2870557
[No Abstract] [Full Text] [Related]
37. [Treatment and prophylaxis of an acute migraine attack].
Diener HC; Gendolla A
MMW Fortschr Med; 2004 Sep; 146(35-36):41, 43-5. PubMed ID: 15540539
[TBL] [Abstract][Full Text] [Related]
38. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
Friberg L; Olesen J; Iversen HK; Sperling B
Lancet; 1991 Jul; 338(8758):13-7. PubMed ID: 1676084
[TBL] [Abstract][Full Text] [Related]
39. [Analgesics and non-steroidal anti-inflammatory agents in the treatment of migraine].
Iglesias F; Pascual J
Rev Neurol; 1995; 23 Suppl 2():S157-61. PubMed ID: 7497280
[No Abstract] [Full Text] [Related]
40. [Drug treatment of migraine attacks. Pharmacological considerations].
Salvesen R
Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2176-9. PubMed ID: 8801661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
